AAAAAA

   
Results: 1-15 |
Results: 15
Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans
Authors: Chan, JR Boger, RH Bode-Boger, SM Tangphao, O Tsao, PS Blaschke, TF Cooke, JP
Citation: Jr. Chan et al., Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans, ART THROM V, 20(4), 2000, pp. 1040-1046
Vascular reactivity in obstructive sleep apnea syndrome
Authors: Duchna, HW Guilleminault, C Stoohs, RA Faul, JL Moreno, H Hoffman, BB Blaschke, TF
Citation: Hw. Duchna et al., Vascular reactivity in obstructive sleep apnea syndrome, AM J R CRIT, 161(1), 2000, pp. 187-191
Optimizing the science of drug development: Opportunities for better candidate selection and accelerated evaluation in humans
Authors: Lesko, LJ Rowland, M Peck, CC Blaschke, TF
Citation: Lj. Lesko et al., Optimizing the science of drug development: Opportunities for better candidate selection and accelerated evaluation in humans, PHARM RES, 17(11), 2000, pp. 1335-1344
Optimizing the science of drug development: Opportunities for better candidate selection and accelerated evaluation in humans
Authors: Lesko, LJ Rowland, M Peck, CC Blaschke, TF
Citation: Lj. Lesko et al., Optimizing the science of drug development: Opportunities for better candidate selection and accelerated evaluation in humans, J CLIN PHAR, 40(8), 2000, pp. 803-814
The disposition of saquinavir in normal and P-glycoprotein deficient mice,rats, and in cultured cells
Authors: Washington, CB Wiltshire, HR Man, M Moy, T Harris, SR Worth, E Weigl, P Liang, ZM Hall, D Marriott, L Blaschke, TF
Citation: Cb. Washington et al., The disposition of saquinavir in normal and P-glycoprotein deficient mice,rats, and in cultured cells, DRUG META D, 28(9), 2000, pp. 1058-1062
Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system
Authors: Zhang, L Gorset, W Washington, CB Blaschke, TF Kroetz, DL Giacomini, KM
Citation: L. Zhang et al., Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system, DRUG META D, 28(3), 2000, pp. 329-334
Nicotine impairs endothelium-dependent dilatation in human veins in vivo
Authors: Chalon, S Moreno, H Benowitz, NL Hoffman, BB Blaschke, TF
Citation: S. Chalon et al., Nicotine impairs endothelium-dependent dilatation in human veins in vivo, CLIN PHARM, 67(4), 2000, pp. 391-397
L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study
Authors: Tangphao, O Chalon, S Coulston, AM Moreno, H Chan, JR Cooke, JP Hoffman, BB Blaschke, TF
Citation: O. Tangphao et al., L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study, VASC MED, 4(1), 1999, pp. 27-32
Pharmacokinetics of intravenous and oral L-arginine in normal volunteers
Authors: Tangphao, O Grossmann, M Chalon, S Hoffman, BB Blaschke, TF
Citation: O. Tangphao et al., Pharmacokinetics of intravenous and oral L-arginine in normal volunteers, BR J CL PH, 47(3), 1999, pp. 261-266
Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins
Authors: Chalon, S Tejura, B Moreno, H Urae, A Blaschke, TF Hoffman, BB
Citation: S. Chalon et al., Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins, BR J CL PH, 47(1), 1999, pp. 91-98
Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia
Authors: Tangphao, O Chalon, S Moreno, H Hoffman, BB Blaschke, TF
Citation: O. Tangphao et al., Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia, CLIN SCI, 96(2), 1999, pp. 199-207
Heparin-induced vasodilation in human hand veins
Authors: Tangphao, O Chalon, S Moreno, HJ Abiose, AK Blaschke, TF Hoffman, BB
Citation: O. Tangphao et al., Heparin-induced vasodilation in human hand veins, CLIN PHARM, 66(3), 1999, pp. 232-238
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers
Authors: Chalon, S Moreno, H Hoffman, BB Blaschke, TF
Citation: S. Chalon et al., Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers, CLIN PHARM, 65(3), 1999, pp. 295-303
Inhibition of angiotensin-converting enzyme in human hand veins
Authors: Chalon, S Bedarida, GV Moreno, H Tejura, B Urae, A Hoffmann, BB Blaschke, TF
Citation: S. Chalon et al., Inhibition of angiotensin-converting enzyme in human hand veins, CLIN PHARM, 65(1), 1999, pp. 58-65
Pharmacodynamics
Authors: Ford, GA Hoffman, BB Blaschke, TF
Citation: Ga. Ford et al., Pharmacodynamics, DRUG THERAPY IN OLD AGE, 1998, pp. 59-72
Risultati: 1-15 |